Evidence for carbimazole as an antioxidant?

Autoimmunity

Volumn 27, Issue 3, 1998, Pages 149-153

  Wilson, Rhoda ^a   Buchanan, Linda ^a   Fraser, William D ^a   Jenkins, Carol ^a   Smith, William E ^a   Reglinski, John ^a   Thomson, John A ^a   McKillop, James H ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Anti oxidants; Antithyroid drugs; Graves' disease

Indexed keywords

ANTIOXIDANT; ANTITHYROID AGENT; CARBIMAZOLE; CERULOPLASMIN; SUPEROXIDE DISMUTASE; THIOL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; THYROID FUNCTION TEST;

EID: 0031960111     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939809003862     Document Type: Article

References (13)

1. Dunn, J. T. (1984). Choice of therapy in young adults with hyperthyroidism of Graves' disease. A brief case directed poll of thyroidologists. Annals of Internal Medicine, 100, 819-821.
2. Wilson, R., Buchanan, L. M., Fraser, W. D., McKillop, J. H. and Thomson, J. A. (1996). Do higher doses of Carbimazole improve remission rates in Graves' disease? Quarterly Journal of Medicine, 89, 381-385.
3. Weetman, A. P., Holt, M. E., Campbell, A. K., Hall, R. and McGregor, A. M. (1984). Methimazole and generation of oxygen radicals by monocytes: potential role in immunosupression. British Medical Journal, 288, 518-520.
4. Wilson, R., Choppra, M., Bradley, H., McKillop, J. H. and Smith, W. E. (1989). Free radicals and Graves' disease: the effects of therapy. Clinical Endocrinology, 30, 429-433.
5. Reglinski, J., Smith, W. E., Wilson, R., Buchanan, L. M., McKillop, J. H. and Thomson, J. A. (1992). Spin echo NMR resonance studies on intact erythrocytes: changes in cellular metabolism as a consequence of Carbimazole therapy. Clinical Endocrinology, 37, 319-324.
6. Garner M., Armstrong, D. R., Reglinski, J., Smith, W. E., Wilson, R. and McKillop, J. H. (1994). The current structure of methimazole and its consequences for current therapeutic models of Graves' disease. Bio-organic Medical Chemistry Letters, 4, 1357-1360.
7. Banford, J. C., Brown, D. M., Hazelton, R. A., McNeil, C. J., Sturrock, R. D. and Smith, W. E. (1992). Altered thiol status in patients with rheumatoid arthritis. Rheumatology International, 2, 107-111.
8. Banford, J. C., Brown, J. C., Hazelton, R. A., McNeil, C. J., Sturrock, R. D. and Smith, W. E. (1982). Serum copper and erythrocyte superoxide dismutase in rheumatoid arthritis. Annals of Rheum, 41, 458-462.
9. Misra, H. P. (1977). Fridovich I Superoxide dismutase, a photochemical augmentation assay. Archives Biochemistry Biophysics, 181, 308-312.
10. Reglinski, J., Smith, W. E., Wilson, R., Buchanan, L. M., McKillop, J. H. and Thomson, J. A. (1992). Spin echo NMR resonance studies on intact erythrocytes: changes in cellular metabolism as a consequence of Carbimazole therapy. Clinical Endocrinology 1992; 37, 319-324.
11. Ellman, G. L. (1959). Tissue sulphydryl groups. Archives of Biochemistry and Biophysics 1959, 82, 70-77.
12. Menden, E. E., Biorano, J. M., Murthy, L. and Petering, H. G. (1977). Modification of a phenylenediamine oxidase. Method to permit caeruloplasmin determinations. Analytical Letters, 197-204.
13. Balazs, C., Kiss, E., Leovey, E. and Farid., N. R. (1986). The immunosuppressive effect of Methimazole on cell - mediated immunity is mediated by its capacity to inhibit peroxidase and to scavenge free oxygen radicals. Clinical Endocrinology, 25, 7-16.